Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Last volunteers to be enrolled in phase I HIV vaccine trial

Sep. 22, 2004

New HIV medication combining two NRTIs recommended for E.U. approval

Sep. 20, 2004

Crucell and IAVI to use AdVac technology to develop AIDS vaccine

Sep. 17, 2004

Remune induces HIV-specific immunity in drug-naive patients

Sep. 16, 2004

IR-103 enters first clinical testing

Sep. 14, 2004

Novel HIV integrase inhibitors prepared and tested at Pfizer

Sep. 13, 2004

Novel HIV integrase inhibitors in early development at BMS

Sep. 9, 2004

ReceptoPharm research into cobra venom potential for HIV

Sep. 6, 2004

Long-term efficacy of efavirenz-containing antiretroviral regimens in HIV infection

Sep. 2, 2004

Preliminary data on the efficacy of a tenofovir/emtricitabine combination in HIV-infected patients

Sep. 2, 2004

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...